ARCHIVES

In Brief: ACS Asks Removal Of Dollar Authorization Levels; FDA May Overrule Advisors On Estramustine

This article is from The Cancer Letter archive.

Vol. 05 No. 47 | November 23, 1979

Download PDF Visit The Full Archive

Related Articles

More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene

August 28, 2009

Two Phase III Trials Show Increase In PFS In Two Distinct Patient Populations

June 28, 2013

HHS Hearings to Form National Breast Cancer Strategy. Shalala Says

October 29, 1993

Cancer Prevention; BCPT Enrollment Final At 13,000 After 5 Years

July 4, 1997

CCIRC Disapproves NCOG Renewal, But Carter Plan Appeal To NCAB; Setback For NCI On Regional Groups

March 6, 1981

Study Opens For Women At Risk of Ovarian Cancer

October 29, 2004